Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an options trading signal again: unusual options activity screeners and strategies. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Therapeuticsmd Inc (TXMD)

Therapeuticsmd Inc (TXMD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 56,644
  • Shares Outstanding, K 9,425
  • Annual Sales, $ 86,950 K
  • Annual Income, $ -172,420 K
  • 60-Month Beta 1.37
  • Price/Sales 0.59
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade TXMD with:

Options Overview Details

View History
  • Implied Volatility 102.15% ( -17.40%)
  • Historical Volatility 114.04%
  • IV Percentile 14%
  • IV Rank 18.58%
  • IV High 535.22% on 05/02/22
  • IV Low 3.32% on 07/05/22
  • Put/Call Vol Ratio 0.67
  • Today's Volume 257
  • Volume Avg (30-Day) 395
  • Put/Call OI Ratio 0.24
  • Today's Open Interest 43,622
  • Open Int (30-Day) 43,013

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.14 +41.55%
on 11/23/22
6.98 -16.05%
on 11/11/22
+0.60 (+11.41%)
since 11/08/22
3-Month
4.14 +41.55%
on 11/23/22
9.03 -35.11%
on 09/12/22
-2.22 (-27.48%)
since 09/08/22
52-Week
1.99 +194.47%
on 05/26/22
30.50 -80.79%
on 01/04/22
-17.27 (-74.66%)
since 12/08/21

Most Recent Stories

More News
Pre-Market Brief: Stocks Mixed As Labor Market Strength Weigh On Sentiment

December S&P 500 futures (ESZ22) are trending down -0.30% this morning after three major US benchmark indices closed mixed on Friday as the November payrolls report fueled expectations the Federal Reserve...

ESZ22 : 3,957.50 (+0.53%)
TXMD : 5.99 (-0.33%)
IOVA : 7.21 (-0.69%)
IMPP : 0.3225 (-5.15%)
CLVS : 0.2229 (+1.32%)
UTHR : 278.57 (+0.54%)
SBUX : 103.79 (+1.88%)
TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma

TherapeuticsMD, Inc. (NASDAQ: TXMD) (“TherapeuticsMD,” “TXMD” or the “Company”), an innovative, leading women’s healthcare company, today announced that it has entered into definitive agreements...

TXMD : 5.99 (-0.33%)
TherapeuticsMD (TXMD) Reports Q3 Loss, Lags Revenue Estimates

TherapeuticsMD (TXMD) delivered earnings and revenue surprises of -53.43% and 30.74%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

TXMD : 5.99 (-0.33%)
IDXG : 1.0315 (-1.76%)
TherapeuticsMD Announces Third Quarter 2022 Financial Results

TherapeuticsMD, Inc. (“TXMD” or the “Company”) (NASDAQ: TXMD), an innovative, leading women’s healthcare company, today reported financial results for the third quarter ended September 30, 2022....

TXMD : 5.99 (-0.33%)
Organogenesis (ORGO) Lags Q3 Earnings and Revenue Estimates

Organogenesis (ORGO) delivered earnings and revenue surprises of -33.33% and 3.74%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

ORGO : 2.69 (+1.51%)
TXMD : 5.99 (-0.33%)
TherapeuticsMD Announces Additional $7 Million Private Placement

TherapeuticsMD, Inc. (NASDAQ: TXMD), (“TherapeuticsMD” or the “Company”) an innovative, leading women’s healthcare company, announced today that it received an additional $7 million private investment...

TXMD : 5.99 (-0.33%)
TherapeuticsMD Announces $7 Million Private Placement

TherapeuticsMD, Inc. (NASDAQ: TXMD), (“TherapeuticsMD” or the “Company”) an innovative, leading women’s healthcare company, announced today that it received a $7 million private investment in...

TXMD : 5.99 (-0.33%)
TherapeuticsMD Appoints Dr. Brian Bernick and Mr. Mark Glickman as Interim Co-Chief Executive Officers

TherapeuticsMD, Inc. (NASDAQ: TXMD), (“TherapeuticsMD” or the “Company”) an innovative, leading women’s healthcare company, announced today the appointment of Dr. Brian Bernick and Mr. Mark Glickman...

TXMD : 5.99 (-0.33%)
TherapeuticsMD, Inc. (TXMD) Q2 2022 Earnings Call Transcript

TXMD earnings call for the period ending June 30, 2022.

TXMD : 5.99 (-0.33%)
TherapeuticsMD (TXMD) Reports Q2 Loss, Tops Revenue Estimates

TherapeuticsMD (TXMD) delivered earnings and revenue surprises of 29.28% and 23.11%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

TXMD : 5.99 (-0.33%)
ADXN : 0.6402 (+2.51%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

TherapeuticsMD, Inc. is a specialty pharmaceutical company focused on creating branded prescription, generic prescription and over-the-counter products targeted exclusively for women. It is developing three advanced hormone replacement products designed to alleviate the symptoms of and reduce the health...

See More

Key Turning Points

3rd Resistance Point 7.55
2nd Resistance Point 6.88
1st Resistance Point 6.44
Last Price 5.99
1st Support Level 5.33
2nd Support Level 4.66
3rd Support Level 4.22

See More

52-Week High 30.50
Fibonacci 61.8% 19.61
Fibonacci 50% 16.25
Fibonacci 38.2% 12.88
Last Price 5.99
52-Week Low 1.99

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar